Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
Chim
C S
CS
Kwong
Y L
YL
D000208:Acute Disease; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002526:Cerebellar Diseases / Q000139:chemically induced*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy*; D008181:Lupus Nephritis / Q000150:complications* / Q000503:physiopathology; D008942:Mitoxantrone / Q000008:administration & dosage
D003561:Cytarabine; D008942:Mitoxantrone; D003630:Daunorubicin